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Introduction: Strains of Panton-Valentine leukocidin-producing Staphylococcus aureus producing a new pattern of
disease have emerged worldwide. Infection with these bacteria typically presents as a life-threatening infection of
soft tissues and bones, and may cause potentially devastating consequences.
Case presentation: We report a case of osteoarticular infection caused by Panton-Valentine leukocidin-producing
Staphylococcus aureus. A 12-year-old Caucasian girl presented with acute osteomyelitis of the tibia associated with
toxic shock syndrome, which was complicated by an unexpected spontaneous ankle arthrodesis.
Conclusions: Osteoarticular infections due to Panton-Valentine leukocidin-producing Staphylococcus aureus appear
to be severe, and are characterized by their tendency to evolve towards serious complications. This case highlights
the need for early and aggressive surgical procedures in conjunction with appropriate antimicrobial therapy and
regular long-term follow-up.Introduction
Panton-Valentine leukocidin (PVL) is a pore-forming
toxin [1], secreted by 2% to 5% of Staphylococcus aureus
strains. This exotoxin induces polymorphonuclear cell
death via necrosis or apoptosis, and the subsequent re-
lease of leukocytic cytokines [2]. Induction of leukocyte
apoptosis by S. aureus may cause extensive tissue necro-
sis and compromise the antimicrobial response, thereby
facilitating bacterial spread [2]. The presence of PVL
genes is associated with an increased risk of more severe
systemic inflammation and serious infection requiring
intensive care [3,4]. PVL-positive staphylococcal infec-
tions may lead to life-threatening infections of soft tis-
sues, such as necrotizing hemorrhagic pneumonia,* Correspondence: dimitri.ceroni@hcuge.ch
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reproduction in any medium, provided the orassociated with a high mortality rate [5-7]. Bone and
joint infections with PVL-producing S. aureus (PVL+
SA) are more aggressive, present a different evolution,
and have a probably higher rate of orthopedic complica-
tions [8]. The purpose of this paper is to report an un-
usual and severe complication resulting from an
osteoarticular infection of PVL + SA.Case presentation
A previously healthy 12-year-old Caucasian girl was
brought to the emergency department of our hospital
complaining of a swollen left ankle and fever. She had a
history of ankle trauma three days before. Her vital signs
included a temperature of 40°C, a pulse rate of 132
beats/minute, a respiratory rate of 22 breaths/minute
and blood pressure of 90/55 mmHg. Her left leg and
ankle were diffusely tender. There was redness on her
foot and the medial aspect of her leg. Laboratory results
showed a white blood cell count of 21,000 cells/mm3, an
elevated C-reactive protein (200 mg/dL; reference range:Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Ceroni et al. Journal of Medical Case Reports 2012, 6:202 Page 2 of 5
http://www.jmedicalcasereports.com/content/6/1/2020 to 10 mg/dL) and an abnormal erythrocyte sedimenta-
tion rate (78 mm/h).
Initial conventional X-rays were normal (Figure 1),
but magnetic resonance imaging (MRI) demonstrated a
large osteomyelitis of her left tibia with an increased
signal intensity in its bone marrow, spreading up to
her mid-tibia (Figures 2 and 3). The MRI of the tibia
showed the presence of intramedullary abscesses and
significant edema of the surrounding muscles (Figure 3).
Our patient was taken to the operating theater, where
she underwent multilevel surgery with pus drainage
and extensive cleaning of the intramedullary cavity,
using 12 liters of saline solution. An intravenous em-
piric antibiotic therapy was immediately started with
flucloxacillin and gentamicin. Abscess cultures were
positive for methicillin-sensitive S. aureus, and a poly-
merase chain reaction (PCR) was positive for PVL. Be-
cause our patient remained symptomatic, she had
revision surgery under general anesthesia four times
over a 17-day period. New recurrent abscesses were
drained each time, and the tibial diaphysis was thor-
oughly washed using 12 liters of isotonic saline solu-
tion. After the fifth intervention, we finally obtained a
resolution of local and biological signs of infection.
Intravenous antibiotics were given for four weeks, fol-
lowed by an oral antibiotic for another four weeks. Six
weeks after the onset of the infection, we noted a se-
vere restriction of the range of motion of her left ankle,
and an X-ray showed an alteration of the tibiotalar
joint line (Figure 4). Two months later, she had total
fusion of the ankle, fortunately in a functional position
(Figure 5).Figure 1 Initial conventional X-ray of the affected tibia. Early frontal an
infiltration.Discussion
PVL is an exotoxin that induces cytotoxic and cytolytic
changes in leukocytes. Complications of infections with
PVL+SA include septic thrombosis, purpura fulminans
and a redoubtable necrotizing pneumonia [9]. Clinical
and biological signs of pulmonary disease are character-
ized by a combination of hemoptysis, multilobar alveolar
infiltrations and leukopenia [9]. Severe pulmonary infec-
tion with PVL+ SA has a mortality rate up to 75% des-
pite intensive medical care [10]. In those cases, intensive
care, antibiotics, aggressive surgical treatment and the
additional application of immunoglobulins is the recom-
mended treatment [9]. It is nevertheless important to
keep in mind that the onset of necrotizing pneumonia
may happen during the evolution of osteoarticular
infection.
Interest in PVL+ SA has progressively increased over
the last years, probably due to the continuing improve-
ment of PVL + SA detection methods with novel PCR
assays. However, to date, only a few papers have focused
specifically on the aspect of bone and joint infections [7-
9,11-13]. The true incidence of osteoarticular infections
caused by PVL+ SA is unknown, probably because the
number of infections due to this strain is underesti-
mated. Ellington et al. found that only 1.6% of S. aureus
from patients with bacteremia in the UK were PVL-
positive [12]. In the USA, the PVL-positive methicillin-
resistant S. aureus (MRSA) strain is responsible for 20%
of bloodstream infections [8], and in Germany, PVL+ SA
became the second most frequent MRSA isolate [14]. In
our department, we noted only two cases of osteoarticu-
lar infections due to PVL+ SA.d lateral conventional X-rays only reveal discrete peritibial soft tissue
Figure 2 Initial magnetic resonance images of the affected
tibia. Overall extension is best understood on magnetic resonance
images with extensive heterogeneous medullar and pericortical
enhancement on T1-weighted fat-suppressed coronal images.
Figure 3 Initial magnetic resonance images of the affected
tibia. The peripheral reactive effusion is explicit on liquid sensitive
inversion-recovery T2-weighted axial images.
Figure 4 Conventional X-ray of the affected tibia 42 days after
surgical drainage and the onset of antibiotic treatment. Frontal
X-ray control after pharmacological and surgical treatment illustrates
the diffuse bone remodeling and sclerosis. Major narrowing of the
tibiotalar joint space illustrates the aggressiveness of the overall
infectious process.
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osteoarticular infections due to PVL+SA has complicated
the conventional management of these infections in chil-
dren [15]. PVL+SA infections of bone and joints induce
more often a concomittant myositis or pyomyositis than
PVL negative SA infections [3]. Furthermore, the bone
infections are more severe, presenting extended diaphysitis
and bone abscesses, and causing more complications [8].
Therefore, osteoarticular infections due to such strains
need longer antibiotic courses and various surgical proce-
dures [8,15]. In children, orthopedic consequences may
arise if the growth cartilage is involved, or if the articular
cartilage is damaged by the infection; unfortunately the
early diagnosis of these sequelae is often difficult.
Figure 5 Late control X-rays of the affected tibia three and a half months after disease onset. Extensive bone remodeling consisted of
cortical thickening, diffuse sclerosis, anatomical deformation and tibiotalar fusion.
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because joint arthrodesis is not commonly encountered after
PVL+SA infections. Nevertheless, the biological characteris-
tics of PVL+SA may explain, from a theoretical point of
view, the onset of spontaneous arthrodesis after an osteoarti-
cular infection. In fact, PVL specifically interacts with and
lyses polymorphonuclear leukocytes, and thus contributes to
the inhibition of infection clearance by the host immune sys-
tem, thereby enabling staphylococcal species to persist [16].
If the infection is not quickly cleared by the host, the potent
activation of the immune response, in association with high
levels of cytokines and reactive oxygen species, increase the
release of host matrix metalloproteinases and other
collagen-degrading enzymes, which in conjunction with bac-
terial toxins lead to joint destruction [17]. The polymorpho-
nuclear response with subsequent release of these
proteolytic enzymes can lead to permanent destruction of
the intra-articular cartilage and subchondral bone loss in as
little as three days [17]. In addition, metalloproteinases and
the antigen-induced inflammatory response may persist and
continue to damage the joint architecture even after the in-
fection has been cleared [18-20].Conclusions
PVL+SA seems to be an emerging and dangerous
pathogen of osteoarticular infections in children. Its evo-
lution is more aggressive, treatment more difficult, and
complications more severe. Even if infections caused by
PVL+SA are currently still uncommon, a PCR-based
assay for toxin gene profiling should be performed in
cases of severe and extended osteoarticular infections or
when severe sepsis occurs. Orthopedic surgeons must be
aware of the possible future changes in the evolutionand behavior of osteoarticular infections in children.
There is probably a subtle balance between an effective
immune response, which eliminates the infecting organ-
ism from the host, and the overactivation of this re-
sponse that causes the majority of infection-related joint
destruction. For this reason, it is now unanimously
recognized that a surgical approach is mandatory for the
management of PVL+ SA osteoarticular infections, in
conjunction with an appropriate antimicrobial therapy,
and long-term follow-up of the affected children is ne-
cessary to recognize late-onset sequelae.Consent
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